NCT01596400: Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years |
|
|
| Completed | 1 | 19 | US | granisetron transdermal system, Sancuso, Granisetron IV | Kyowa Kirin Pharmaceutical Development Ltd | Chemotherapy Induced Nausea and Vomiting | 08/15 | 12/16 | | |
